Iron oxide-coupled CRISPR-nCas9-based genome editing assessment in mucopolysaccharidosis IVA mice.

"Declaration of interests The authors declare no conflict of interest."

"A.F.L. received a PhD scholarship from Pontificia Universidad Javeriana. C.J.A.D was supported by 10.13039/501100009543Pontificia Universidad Javeriana (Investigar PUJ 20386, 20567, and 20646), Ministry of Science, Technology, and Innovation from Colombia (Contract 120380763212, ID 8352, and CT-499-2021, ID 9630), and the 10.13039/100013927National MPS Society (ID 9507). This work was also supported by grants from the Austrian MPS society, A Cure for Robert, Inc., The Carol Ann Foundation, Angelo R. Cali & Mary V. 10.13039/100002769Couch Family Foundation, Inc., The Vain and 10.13039/100006810Hyde Family Foundation, Inc., 10.13039/100018298The Bennett Foundation, Jacob Randall Foundation, and Nemours Funds. S.T. was supported by an Institutional Development Award from the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health (NICHD) (1R01HD10254501A1)."